BamSEC and AlphaSense Join Forces
Learn More

AbbVie Inc.

NYSE: ABBV    
Share price (1/8/25): $178.50    
Market cap (1/8/25): $315 billion

Material Contracts Filter

EX-10.5
from 10-Q 16 pages Material contract
12/34/56
EX-10.4
from 10-Q 18 pages Material contract
12/34/56
EX-10.3
from 10-Q 9 pages Material contract
12/34/56
EX-10.2
from 10-Q 18 pages Material contract
12/34/56
EX-10.1
from 10-Q 19 pages Material contract
12/34/56
EX-10.1
from 10-Q 2 pages Amendment to the Abbvie 2013 Performance Incentive Plan This First Amendment (This “Amendment”) to the Abbvie 2013 Performance Incentive Plan (As Amended and Restated as of January 1, 2022) (The “Plan”) Is Hereby Adopted as of September 8, 2023 (The “Effective Date”). Whereas, Abbvie Inc., a Delaware Corporation (The “Company”), Maintains the Plan and the Company Desires to Amend the Plan to Reflect the Company’s Forfeiture and Clawback Policies. Now, Therefore, the Plan Is Amended, Effective as of the Effective Date, to Add a New Section 2.5, Which Shall Read in Its Entirety as Follows: “Forfeiture and Clawback Provisions. Notwithstanding Any Other Terms or Conditions of the Plan, All Awards (Including Any Proceeds, Gains, or Other Economic Benefit Actually or Constructively Received By, or for the Benefit Of, a Participant With Respect to Any Award (Collectively “Benefits”)) Shall Be Subject to Forfeiture, Recovery, Recoupment, Clawback, and/or Repayment, at the Discretion of the Committee, to the Extent and in the Event the Participant Has Engaged in Misconduct Constituting a Material Breach of the Company Code of Business Conduct. Further, Without Limitation of the Foregoing, All Benefits With Respect to Awards Allocated After September 8, 2023 Shall Be Subject to the Company’s Amended and Restated Clawback Policy (As Amended From Time to Time).” [Remainder of Page Intentionally Left Blank.]
12/34/56
EX-10.6
from 10-Q 15 pages Material contract
12/34/56
EX-10.5
from 10-Q 28 pages Material contract
12/34/56
EX-10.4
from 10-Q 29 pages Material contract
12/34/56
EX-10.3
from 10-Q 9 pages Material contract
12/34/56
EX-10.2
from 10-Q 32 pages Material contract
12/34/56
EX-10.1
from 10-Q 33 pages Material contract
12/34/56
EX-10.2
from 10-Q 21 pages Material contract
12/34/56
EX-10.1
from 8-K 22 pages Form of Agreement Regarding Change in Control
12/34/56
EX-10.6
from 10-Q 14 pages Abbvie Non-Employee Directors’ Fee Plan (Amended and Restated Effective as of May 6, 2022) Abbvie Non-Employee Directors’ Fee Plan Section 1. Purpose
12/34/56
EX-10.6
from 10-Q 26 pages Abbvie Inc. Restricted Stock Unit Agreement
12/34/56
EX-10.5
from 10-Q 26 pages Abbvie Inc. Restricted Stock Unit Agreement
12/34/56
EX-10.4
from 10-Q 29 pages Abbvie Inc. Non-Qualified Stock Option Agreement
12/34/56
EX-10.3
from 10-Q 7 pages Abbvie Inc. Non-Employee Director Restricted Stock Unit Agreement
12/34/56
EX-10.2
from 10-Q 30 pages Abbvie Inc. Performance Share Award Agreement
12/34/56